GlassScriptPhysician profile
Latonya Washington
NPI 1801010061
$5,226.61
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $61.64 · 2021: $4,532 · 2022: $236 · 2023: $81.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $81.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $81.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,500.00 | 2021 | |
| Novo Nordisk INC | $297.74 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $131.10 | 2019-2021 | |
| Glaxosmithkline, LLC. | $81.04 | 2023 | |
| Medtronic Vascular, INC. | $75.72 | 2019 | |
| Terumo Medical Corporation | $52.67 | 2019 | |
| Pfizer INC. | $48.73 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.76 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $14.06 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $10.79 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Latonya Washington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.